Bayer's Sebastian Guth at Endpoints #BIO22 (J.T. MacMillan Photography for Endpoints News)
Bayer's research and development teams settle into new, $140M Kendall Square digs
Bayer spent a considerable amount of time during the pandemic — and $140 million in cash — to build out the top two floors at 238 Main …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
